Shared Resources

Agency for Healthcare Research and Quality (AHRQ)

The Agency for Healthcare Research and Quality's (AHRQ) mission is to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. Information from AHRQ's research helps people make more informed decisions and improve the quality of health care services. AHRQ was formerly known as the Agency for Health Care Policy and Research.

National Institutes for Health (NIH)

NIH is the steward of medical and behavioral research for the Nation. Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability.

American Society of Health-System Pharmacists (ASHP)

The ASHP Foundation is committed to advancing optimal patient outcomes and to the design and study of safe and effective medication-use systems. To that end, the ASHP Foundation offers a number of research grant programs that foster young investigators and/or encourage collaborative, multidisciplinary study.

National Alliance for Research on Schizophrenia and Depression (NARSAD)

NARSAD supports scientific research to find better treatments and ultimately prevent severe mental illnesses. NARSAD offers grants to scientists conducting neurobiological research at a university or research institution. Since 1987, NARSAD has awarded over $238 million in the form of 3,516 research grants. Both U.S. and international applicants are eligible to apply.

The Stanley Medical Research Institute

Since 1989, SMRI has supported a research grants program that has covered a wide spectrum of approaches to research on schizophrenia and bipolar disorder. In the intervening years, other sources of funds have become available. In addition, it has become increasingly apparent to SMRI that some research areas that are promising are being comparatively underfunded. After reviewing research funding available from NIMH, NARSAD, the British Medical Research Council, the Wellcome Trust, the European Community, and other sources, SMRI has decided to focus its funds on four areas only: 1) Treatment trials and drug development; 2) Genetics research leading to the development of new medication; 3) Infectious agents as possible causes of schizophrenia and bipolar disorder; 4) Neuropathology of schizophrenia and bipolar disorder.

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.